Dear Doctor Letter (Rote-Hand-Brief) on Revlimid® (lenalidomide): Occurrence of venous and arterial thromboembolic events
2010.12.27
Active substance: lenalidomide
Important safety-relevant information on the occurrence of venous and arterial thromboembolic events associated with Revlimid® (lenalidomide).
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN